Jean‐Philippe Peyrat

Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients

Maxime P. Look, Wim L.J. van Putten, Michael J. Duffy et al. · JNCI Journal of the National Cancer Institute · 2002 · 604 citations · Full text

Medicine, Biostatistics, Oncology +15

Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer

Timothy R. Rebbeck, Nandita Mitra, Fei Wan et al. · JAMA · 2015 · 509 citations · Full text

Medicine, Genetics, Oncology +17

Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer

Jean‐Philippe Peyrat, M M Louchez, J Lefèbvre et al. · European Journal of Cancer · 1993 · 279 citations

Medicine, Endocrinology, Oncology +6

Human Atlas of the Cardiac Fiber Architecture: Study on a Healthy Population

Hervé Lombaert, Jean‐Philippe Peyrat, Pierre Croisille et al. · IEEE Transactions on Medical Imaging · 2012 · 221 citations

Medicine, Anatomy, Cardiology +17

Insulin-like growth factor 1 receptors in human breast cancer and their relation to estradiol and progesterone receptors.

Jean‐Philippe Peyrat, Jacques Bonneterre, R. Beuscart et al. · PubMed · 1988 · 174 citations

Medicine, Biochemistry, Oncology +9